|Last Price$57.97||Day Change (%)-0.31%|
|Open Price$58.17||Day Change ($)-0.18|
|Day Range57.85–58.34||52-Week Range44.62–59.84|
As of Mon 07/28/2014 05:24 PM EST | USD
The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.
American's managers have been busy buying unloved large caps.
Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.
With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.
ADR Shares End Mixed; Portugal Telecom, Oi Shares Trade Actively
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
ETFs provide a great means to gain exposure to this battered health-care giant.